Discover
BBLG
Bone Biologics Corporation
0.52
2 x 0.37
2 x 0.71
bid
ask
+
0.02
3.82%
2 @ 07:44 PM
0.52 +0.00 (0.19%)
| Ytd | -64.21% | |
| 1y | -75.75% |
0.50
day range
0.52
0.50
52 week range
2.79
| Open | 0.52 | Prev Close | 0.50 | Low | 0.50 | High | 0.52 | Mkt Cap | 1.43M |
| Vol | 126.74K | Avg Vol | 383.92K | EPS | -0.28 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 0.74 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.82 | 200-d Avg | 1.26 | 1yr Est | 16.75 |
| Income Statement | |||
| Operating Expenses | 808.11K | ||
| Research and Development Expense | 308.75K | ||
| Selling, General and Administrative Expense | 499.36K | ||
| Operating Income | -808.11K | ||
| Net Income | -773.70K | ||
| Net Income Common Stock | -773.70K | ||
| Net Income Common Stock (USD) | -773.70K | ||
| Consolidated Income | -773.70K | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -773.70K | ||
| Earning Before Interest & Taxes (USD) | -773.70K | ||
| Weighted Average Shares | 1.80M | ||
| Weighted Average Shares Diluted | 1.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.03M | ||
| Cash and Equivalents (USD) | 4.03M | ||
| Current Assets | 4.44M | ||
| Total Assets | 4.44M | ||
| Current Liabilities | 512.02K | ||
| Total Liabilities | 512.02K | ||
| Accumulated Retained Earnings (Deficit) | -89.67M | ||
| Shareholders Equity | 3.92M | ||
| Shareholders Equity (USD) | 3.92M | ||
| Trade and Non-Trade Payables | 511.47K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 20.18K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -498.26K | ||
| Issuance (Purchase) of Equity Shares | 20.18K | ||
| Net Cash Flow from Operations | -518.44K | ||
| Share Based Compensation | 8.25K | ||